Actionnariat et activité des initiés pour Adaptive Biotechnologies Corporation (ADPT): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $24.20 |
| Capitalisation | $3.9B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-31 | OWEN KATEY EINTERZ | G-Gift | 12,539 | |
| 2026-08-26 | OWEN KATEY EINTERZ | S-Sale | 9,615 | $250K |
| 2026-08-18 | HERSHBERG ROBERT | M-Exempt | 15,000 | $95K |
| 2026-08-18 | HERSHBERG ROBERT | S-Sale | 15,000 | $366K |
| 2026-08-18 | HERSHBERG ROBERT | S-Sale | 15,664 | $382K |
| 2026-08-18 | HERSHBERG ROBERT | M-Exempt | 15,000 | $95K |
| 2026-08-17 | ROBINS CHAD M | M-Exempt | 321,324 | $2.1M |
| 2026-08-18 | ROBINS CHAD M | M-Exempt | 278,676 | $1.8M |
| 2026-08-17 | ROBINS CHAD M | S-Sale | 318,799 | $8.0M |
| 2026-08-18 | ROBINS CHAD M | S-Sale | 278,472 | $6.8M |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $85.3M | $55.0M | $96.6M | $123.4M | $139.1M | $90.0M | $65.1M | $47.9M | $70.5M |
| Placements à Court Terme | $106.8M | $110.0M | $480.3M | $564.8M | $214.0M | $408.2M | $281.3M | $174.4M | $156.5M |
| Créances | $5.6M | $4.8M | $12.7M | $10.0M | $17.4M | $40.1M | $38.0M | $41.7M | $50.4M |
| Stocks | $4.8M | $7.8M | $9.1M | $14.1M | $19.3M | $14.5M | $14.4M | $8.4M | $9.8M |
| Actifs Courants | $205.2M | $180.7M | $612.7M | $726.9M | $402.7M | $562.1M | $410.2M | $283.8M | $300.2M |
| Immobilisations Corporelles | $14.0M | $19.1M | $60.4M | $139.0M | $172.9M | $164.2M | $120.3M | $94.4M | $74.7M |
| Goodwill | $119.0M | $119.0M | $119.0M | $119.0M | $119.0M | $119.0M | $119.0M | $119.0M | $119.0M |
| Actifs Incorporels | $15.3M | $13.6M | $11.9M | $10.2M | $8.5M | $6.8M | $5.1M | $3.4M | $1.7M |
| Actifs Totaux | $362.5M | $332.7M | $912.3M | $1.12B | $923.3M | $856.6M | $661.1M | $539.4M | $512.7M |
| Dettes Fournisseurs | $2.0M | $1.8M | $4.5M | $3.2M | $3.3M | $8.1M | $7.7M | $7.3M | $6.5M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $13.6M |
| Passifs Courants | $21.0M | $22.8M | $78.3M | $105.2M | $113.8M | $109.8M | $88.0M | $98.1M | $89.9M |
| Dette à Long Terme | 0 | $561.2M | 0 | 0 | 0 | 0 | 0 | 0 | $196.8M |
| Passifs Totaux | $587.1M | $590.8M | $341.3M | $373.1M | $319.2M | $392.5M | $352.9M | $336.9M | $287.7M |
| Réserves | -$249.4M | -$295.9M | -$365.5M | -$511.6M | -$718.9M | -$919.1M | -$1.14B | -$1.30B | -$1.36B |
| Capitaux Propres | -$224.6M | -$258.1M | $571.0M | $743.3M | $604.0M | $464.2M | $308.4M | $202.7M | $218.8M |
| Dette Totale | $561.7M | $561.2M | $36.6M | $107.9M | $111.7M | $108.0M | $98.8M | $89.4M | $280.6M |
| Dette Nette | $369.5M | $396.2M | -$540.3M | -$580.4M | -$241.3M | -$390.2M | -$247.6M | -$132.9M | $53.6M |
| Fonds de Roulement | $184.2M | $157.9M | $534.4M | $621.7M | $288.9M | $452.4M | $322.2M | $185.7M | $210.3M |
Santé financière
| Dette / Capitaux propres | 2.87 |
| Ratio de liquidité | 4.79 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 2.08 |
Rentabilité
| Rentabilité des capitaux propres | -32.64% |
| Rentabilité du capital investi | -6.67% |
| Rentabilité des actifs | -9.97% |
| Marge brute | 75.44% |
| Marge opérationnelle | -12.16% |
| Marge nette | -20.73% |
Entreprises liées: BEAM · CDTX · CPRX · IDYA · IRON · LEGN · MLYS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ADPT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions